NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
Reaffirms Lupin’s commitment to sustainable resource management
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
The celebrations began with the unveiling of the Biocon Anthem
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
The product will be marketed by Dr. Reddy's
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Subscribe To Our Newsletter & Stay Updated